ID   Capan-26
AC   CVCL_C0VB
DR   cancercelllines; CVCL_C0VB
DR   Wikidata; Q112929363
RX   PubMed=33788731;
CC   Population: Caucasian; Lithuanian.
CC   Doubling time: 74 hours (PubMed=33788731).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Glu37_Asn86del; Zygosity=Heterozygous (PubMed=33788731).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val172Phe (c.514G>T); ClinVar=VCV000428909; Zygosity=Unspecified (PubMed=33788731).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
RX   PubMed=33788731; DOI=10.21873/anticanres.14897;
RA   Zalyte E., Dedonyte V., Kurlinkus B., Sileikis A., Schemmer P.,
RA   Valius M.;
RT   "Establishment and characterization of a new pancreatic ductal
RT   adenocarcinoma cell line Capan-26.";
RL   Anticancer Res. 41:1401-1406(2021).
//